Cosmos Health signs 5-year Pharmex contract manufacturing deal for 2.86 million dermatology product units

Cosmos Health Inc

Cosmos Health Inc

COSM

0.00
  • Cosmos Health signed a five-year contract manufacturing agreement with Pharmex to produce three dermatology products.
  • Combined volumes set at about 2,860,000 units over the term, supporting higher utilization of its EU manufacturing capacity.
  • Largest product line targets 2,250,000 units over five years; two other products total 610,000 units.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606170927OMX_____CNEWS_EN_GNW9748488_en) on June 17, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.